These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30967312)

  • 1. On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Schartau S; Heering Holt D; Lützen T; Rytter D; Mølbak K
    Vaccine; 2019 May; 37(19):2580-2585. PubMed ID: 30967312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Ulendorf Jacobsen S; Valentiner-Branth P; Mølbak K
    Vaccine; 2018 Oct; 36(41):6158-6162. PubMed ID: 30201304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.
    Bonaldo G; Vaccheri A; D'Annibali O; Motola D
    Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis.
    Krogsgaard LW; Petersen I; Plana-Ripoll O; Bech BH; Lützen TH; Thomsen RW; Rytter D
    PLoS Med; 2021 Sep; 18(9):e1003768. PubMed ID: 34495975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following school-based vaccination of girls with quadrivalent human papillomavirus vaccine in Slovenia, 2009 to 2013.
    Šubelj M; Učakar V; Kraigher A; Klavs I
    Euro Surveill; 2016; 21(14):. PubMed ID: 27103551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    Mølbak K; Hansen ND; Valentiner-Branth P
    PLoS One; 2016; 11(9):e0162520. PubMed ID: 27611088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
    Krogsgaard LW; Bech BH; Plana-Ripoll O; Thomsen RW; Rytter D
    Vaccine; 2019 Mar; 37(13):1763-1768. PubMed ID: 30803841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy.
    Scavone C; Di Mauro C; Brusco S; Bertini M; di Mauro G; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Expert Opin Drug Saf; 2019 May; 18(5):427-433. PubMed ID: 30907147
    [No Abstract]   [Full Text] [Related]  

  • 12. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
    Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M
    J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.
    Krogsgaard LW; Helmuth IG; Bech BH; Plana-Ripoll O; Lützen TH; Vestergaard HT; Bjerre KD; Thomsen RW; Mølbak K; Rytter D
    Vaccine; 2020 Jul; 38(35):5678-5684. PubMed ID: 32624249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-being of women referred due to suspected side effects after human papilloma virus vaccination.
    Kjaer J; Jensen TS; Rolving N; Sørensen VN; Blaakaer J; Hammer A
    Dan Med J; 2020 Jun; 67(6):. PubMed ID: 32741432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016).
    Mauro AB; Fernandes EG; Miyaji KT; Arantes BA; Valente MG; Sato HK; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2019 Sep; 61():e43. PubMed ID: 31531621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
    Lei J; Balakrishnan MR; Gidudu JF; Zuber PLF
    Vaccine; 2018 Mar; 36(12):1577-1582. PubMed ID: 29454518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
    Tafuri S; Fortunato F; Gallone MS; Stefanizzi P; Calabrese G; Boccalini S; Martinelli D; Prato R
    Vaccine; 2018 Feb; 36(8):1072-1077. PubMed ID: 29358055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
    Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.